{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00374",
      "entity_text" : "NMDA receptor",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3821",
      "entity_text" : "ketamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Interestingly, the nonselective NMDA receptor antagonist ketamine produces a fast and sustained reduction of depressive symptoms in patients with TRD, supporting this hypothesis [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T13:56:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:46:47Z",
  "trigger" : "antagonist",
  "evidence" : [ "NMDA receptor antagonist ketamine" ],
  "pmc_id" : "5384360",
  "score" : 0
}